Cargando…
Multiplex PCR and Next Generation Sequencing for the Non-Invasive Detection of Bladder Cancer
BACKGROUND: Highly sensitive and specific urine-based tests to detect either primary or recurrent bladder cancer have proved elusive to date. Our ever increasing knowledge of the genomic aberrations in bladder cancer should enable the development of such tests based on urinary DNA. METHODS: DNA was...
Autores principales: | Ward, Douglas G., Baxter, Laura, Gordon, Naheema S., Ott, Sascha, Savage, Richard S., Beggs, Andrew D., James, Jonathan D., Lickiss, Jennifer, Green, Shaun, Wallis, Yvonne, Wei, Wenbin, James, Nicholas D., Zeegers, Maurice P., Cheng, KK, Mathews, Glenn M., Patel, Prashant, Griffiths, Michael, Bryan, Richard T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4762704/ https://www.ncbi.nlm.nih.gov/pubmed/26901314 http://dx.doi.org/10.1371/journal.pone.0149756 |
Ejemplares similares
-
Toward Personalised Liquid Biopsies for Urothelial Carcinoma: Characterisation of ddPCR and Urinary cfDNA for the Detection of the TERT 228 G>A/T Mutation
por: Russo, Ilaria J., et al.
Publicado: (2018) -
Exploring the roles of urinary HAI-1, EpCAM & EGFR in bladder cancer prognosis & risk stratification
por: Snell, Kym I.E., et al.
Publicado: (2018) -
Use of Aleuria alantia Lectin Affinity Chromatography to Enrich Candidate Biomarkers from the Urine of Patients with Bladder Cancer
por: Ambrose, Sarah R., et al.
Publicado: (2015) -
Targeted deep sequencing of urothelial bladder cancers and associated urinary DNA: a 23‐gene panel with utility for non‐invasive diagnosis and risk stratification
por: Ward, Douglas G., et al.
Publicado: (2019) -
STAG2 Protein Expression in Non–muscle-invasive Bladder Cancer: Associations with Sex, Genomic and Transcriptomic Changes, and Clinical Outcomes
por: Gordon, Naheema S., et al.
Publicado: (2022)